[1] Hong G, Kuek V, Shi J, et al.EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis[J]. J Cell Physiol, 2018, 233(11): 8526-8537. [2] Fitch MJ, Campagnolo L, Kuhnert F, et al.Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells[J]. Dev Dyn, 2004, 230(2): 316-324. [3] Parker LH, Schmidt M, Jin SW, et al.The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation[J]. Nature, 2004, 428(6984): 754-758. [4] Bambino K, Lacko LA, Hajjar KA, et al.Epidermal growth factor-like domain 7 is a marker of the endothelial lineage and active angiogenesis[J]. Genesis, 2014, 52(7): 657-670. [5] Poissonnier L, Villain G, Soncin F, et al.Egfl7 is differentially expressed in arteries and veins during retinal vascular development[J]. PLoS One, 2014, 9(3): e90455. [6] Liu YS, Huang ZW, Qin AQ, et al.The expression of epidermal growth factor-like domain 7 regulated by oxygen tension via hypoxia inducible factor (HIF)-1α activity[J]. Postgrad Med, 2015, 127(2): 144-149. [7] Schmidt M, Paes K, De Mazière A, et al.EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution[J]. Development, 2007, 134(16): 2913-2923. [8] De Mazière A, Parker L, Van Dijk S, et al.Egfl7 knockdown causes defects in the extension and junctional arrangements of endothelial cells during zebrafish vasculogenesis[J]. Dev Dyn, 2008, 237(3): 580-591. [9] Nikolic I, Stankovic ND, Bicker F, et al.EGFL7 ligates αvβ3 integrin to enhance vessel formation[J]. Blood, 2013, 121(15): 3041-3050. [10] Rossi A, Kontarakis Z, Gerri C, et al.Genetic compensation induced by deleterious mutations but not gene knockdowns[J]. Nature, 2015, 524(7564): 230-233. [11] Nichol D, Shawber C, Fitch MJ, et al.Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7[J]. Blood, 2010, 116(26): 6133-6143. [12] Lacko LA, Hurtado R, Hinds S, et al.Altered feto-placental vascularization, feto-placental malperfusion and fetal growth restriction in mice with Egfl7 loss of function[J]. Development, 2017, 144(13): 2469-2479. [13] Massimiani M, Vecchione L, Piccirilli D, et al.Epidermal growth factor-like domain 7 promotes migration and invasion of human trophoblast cells through activation of MAPK, PI3K and NOTCH signaling pathways[J]. Mol Hum Reprod, 2015, 21(5): 435-451. [14] Davis GE.Vascular balancing act: EGFL7 and Notch[J]. Blood, 2010, 116(26): 5791-5793. [15] Bicker F, Vasic V, Horta G, et al.Neurovascular EGFL7 regulates adult neurogenesis in the subventricular zone and thereby affects olfactory perception[J]. Nat Commun, 2017, 8: 15922. [16] Renz M, Otten C, Faurobert E, et al.Regulation of β1 integrin-Klf2-mediated angiogenesis by CCM proteins[J]. Dev Cell, 2015, 32(2): 181-190. [17] Yang RH, Qi SH, Ruan SB, et al.EGFL7-overexpressing epidermal stem cells promotes fibroblast proliferation and migration via mediating cell adhesion and strengthening cytoskeleton[J]. Mol Cell Biochem, 2016, 423(1-2): 1-8. [18] Deford P, Brown K, Richards RL, et al.MAGP2 controls Notch via interactions with RGD binding integrins: Identification of a novel ECM-integrin-Notch signaling axis[J]. Exp Cell Res, 2016, 341(1): 84-91. [19] Takeuchi K, Yanai R, Kumase F, et al.EGF-like-domain-7 is required for VEGF-induced Akt/ERK activation and vascular tube formation in an ex vivo angiogenesis assay[J]. PLoS One, 2014, 9(3): e91849. [20] Chim SM, Kuek V, Chow ST, et al.EGFL7 is expressed in bone microenvironment and promotes angiogenesis via ERK, STAT3, and integrin signaling cascades[J]. J Cell Physiol, 2015, 230(1): 82-94. [21] 曹玉净, 吕秋霞. 类表皮生长因子域7通过 ERK 信号通路促进内皮细胞迁移及血管生成[J]. 中华病理学杂志, 2015, 44(4): 270-273. [22] d'Audigier C, Susen S, Blandinieres A, et al. Egfl7 represses the vasculogenic potential of human endothelial progenitor cells[J]. Stem Cell Rev, 2018, 14(1): 82-91. [23] Badiwala MV, Tumiati LC, Joseph JM, et al.Epidermal growth factor-like domain 7 suppresses intercellular adhesion molecule 1 expression in response to hypoxia/reoxygenation injury in human coronary artery endothelial cells[J]. Circulation, 2010, 122(11 Suppl): S156-S161. [24] Charpentier MS, Christine KS, Amin NM, et al.CASZ1 promotes vascular assembly and morphogenesis through the direct regulation of an EGFL7/RhoA-mediated pathway[J]. Dev Cell, 2013, 25(2): 132-143. [25] 杜仲, 马海龙, 张凌, 等. TIE2-R849W突变斑马鱼模型的建立及其在静脉畸形发病中的作用探讨[J]. 中国口腔颌面外科杂志, 2018, 16(1): 6-11. [26] 贺月华, 冯雷, 罗亚楠, 等. EGFL7和FAK在婴幼儿血管瘤组织中的表达及其相关性[J]. 中国皮肤性病学杂志, 2018, 32(6): 620-623. [27] Johnson L, Huseni M, Smyczek T, et al.Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy[J]. J Clin Invest, 2013, 123(9): 3997-4009. |